Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000996411 | SCV001151099 | likely pathogenic | not provided | 2016-08-01 | criteria provided, single submitter | clinical testing | |
Paris Brain Institute, |
RCV000007222 | SCV001451061 | pathogenic | Hereditary spastic paraplegia 7 | criteria provided, single submitter | clinical testing | ||
Institute of Medical Genetics and Applied Genomics, |
RCV000007222 | SCV002822947 | pathogenic | Hereditary spastic paraplegia 7 | 2023-01-20 | criteria provided, single submitter | clinical testing | second pathogenic variant identified |
PROSPAX |
RCV000007222 | SCV005044598 | pathogenic | Hereditary spastic paraplegia 7 | 2022-01-01 | criteria provided, single submitter | research | |
OMIM | RCV000007222 | SCV000027418 | pathogenic | Hereditary spastic paraplegia 7 | 2010-05-01 | no assertion criteria provided | literature only | |
Diagnostic Laboratory, |
RCV000996411 | SCV001978458 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000996411 | SCV001979445 | likely pathogenic | not provided | no assertion criteria provided | clinical testing |